Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.11943 | 76 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.87581 | 74 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.87199 | 74 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.62102 | 71 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.81664 | 74 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.18423 | 78 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.32141 | 79 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.95229 | 75 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.7881 | 74 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.71019 | 73 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.88941 | 74 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.71793 | 73 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.10141 | 76 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.90777 | 75 |